Show simple item record

dc.contributor.authorChan Wah Hak, C
dc.contributor.authorBalyasnikova, S
dc.contributor.authorWithey, S
dc.contributor.authorTait, D
dc.contributor.authorBrown, G
dc.contributor.authorChong, I
dc.date.accessioned2023-11-07T14:54:44Z
dc.date.available2023-11-07T14:54:44Z
dc.date.issued2023-10-27
dc.identifier.citationCancers, 2023, 15 (21), pp. 5176 - 5176
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/6046
dc.identifier.eissn2072-6694
dc.identifier.eissn2072-6694
dc.identifier.doi10.3390/cancers15215176
dc.identifier.doi10.3390/cancers15215176
dc.description.abstractOur study evaluated whether an MRI reporting system highlighting areas of contiguous and discontinuous extramural venous invasion (EMVI) can improve the accuracy of gross tumour volume (GTV) delineation. Initially, 27 consecutive patients with locally advanced rectal cancer treated between 2012 and 2014 were evaluated. We used an MRI reporting proforma that documented the position of the primary tumour, lymph nodes and EMVI. The new GTVs delineated were compared with historical radiotherapy treatment volumes to identify the frequency of GTV geographical miss. We observed that the delineation of involved nodes and areas of EMVI was more likely to represent sources of uncertainty wherein nodal GTV geographical miss was evident in 5 out of 27 patients (19%). Complete EMVI GTV geographical miss occurred in two patients (7%). We re-evaluated our radiotherapy practice in a further 27 patients after the implementation of a modified MRI reporting system. An improvement was seen; nodal miss was observed in two patients (7%) and partial EMVI miss in one patient (4%), although these areas were encompassed in the planning target volume (PTV). Our study shows that extramural venous invasion and involved nodes need to be highlighted on MRI to improve the accuracy of rectal cancer GTV delineation.
dc.format.extent5176 - 5176
dc.languageen
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofCancers
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleRadiological Biomarkers in MRI directed Rectal Cancer Radiotherapy Volume Delineation.
dc.typeJournal Article
dcterms.dateAccepted2023-10-25
dc.date.updated2023-11-01T12:14:00Z
rioxxterms.versionVoR
rioxxterms.versionofrecord10.3390/cancers15215176
rioxxterms.licenseref.startdate2023-10-27
rioxxterms.typeJournal Article/Review
pubs.issue21
pubs.organisational-groupICR
pubs.organisational-groupICR/Primary Group
pubs.organisational-groupICR/Primary Group/ICR Divisions
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Immunotherapy
pubs.organisational-groupICR/Students
pubs.organisational-groupICR/Students/PhD and MPhil
pubs.organisational-groupICR/Students/PhD and MPhil/21/22 Starting Cohort
pubs.publication-statusPublished online
pubs.publisher-urlhttp://dx.doi.org/10.3390/cancers15215176
pubs.volume15
icr.researchteamTrans Immunotherapy
dc.contributor.icrauthorChan Wah Hak, Charleen Min Li
icr.provenanceDeposited by Dr Charleen Chan Wah Hak on 2023-11-01. Deposit type is initial. No. of files: 1. Files: Cancers manuscript_2023.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/